~~<i id='C79153E7E7'><strike id='C79153E7E7'><tt id='C79153E7E7'><pre id='C79153E7E7'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-10-04 05:04:02 Page View：9545

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The mammogram wars are not over
Next article： Virginia high school admissions case could be legal follow

leisure time

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

2:29Sen.JohnBarrassoreachesouttohelpSenateMinorityLeaderMitchMcConnellafterMcConnellfrozeandstoppedt

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

FILE-AmericanAirlinesplanesareparkedatPittsburghInternationalAirportonMarch31,2020,inImperial,Pa.Ame

WSS

explore

explore

focus

leisure time

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating